tirzepatide lean mass decline
7 Reasons Semaglutide Outperforms Tirzepatide in Lean‑Mass Preservation
Answer: Tirzepatide drives more overall weight loss than semaglutide, but it also leads to a larger decline in lean body mass. In 2023 the United States experienced a 30% surge in GLP-1 prescriptions, reflecting both patient demand and aggressive marketing. That wave has brought two rival drugs - tirzepatide (Lilly)